Venkat Ramanathan
Overview
Explore the profile of Venkat Ramanathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raasikh T, Jamali T, Flores A, Cotton R, Ramanathan V, Tan H, et al.
Aliment Pharmacol Ther
. 2021 Jul;
54(5):571-582.
PMID: 34265111
Background: Given the success of direct-acting antivirals (DAAs) in treating hepatitis C (HCV), interest is growing in utilizing solid organs from allografts with active HCV to expand donor availability. Aim:...
2.
Vangala C, Shah M, Dave N, Al Attar L, Navaneethan S, Ramanathan V, et al.
Ren Fail
. 2021 Jul;
43(1):1146-1154.
PMID: 34261420
Background: Outpatient dialysis is standardized with several evidence-based measures of adequacy and quality that providers aim to meet while providing treatment. By contrast, in the intensive care unit (ICU) there...
3.
Efe O, McGrath M, Hu F, Ramanathan V, Cotton R, Adler J, et al.
Kidney Med
. 2021 Apr;
3(2):307-308.
PMID: 33851129
No abstract available.
4.
Khairallah P, Aggarwal N, Awan A, Vangala C, Airy M, Pan J, et al.
Transpl Int
. 2021 Feb;
34(4):612-621.
PMID: 33545741
The COVID-19 pandemic has significantly changed the landscape of kidney transplantation in the United States and worldwide. In addition to adversely impacting allograft and patient survival in postkidney transplant recipients,...
5.
Navaneethan S, Akeroyd J, Ramsey D, Ahmed S, Mishra S, Petersen L, et al.
Clin J Am Soc Nephrol
. 2018 Dec;
13(12):1842-1850.
PMID: 30498000
Background And Objectives: Facility-level variation has been reported among veterans receiving care for various diseases. We studied the frequency and facility-level variations of guideline-recommended practices in patients with diabetes and...
6.
Awan A, Niu J, Pan J, Erickson K, Mandayam S, Winkelmayer W, et al.
Am J Nephrol
. 2018 Nov;
48(6):472-481.
PMID: 30472701
Background: Death with graft function remains an important cause of graft loss among kidney transplant recipients (KTRs). Little is known about the trend of specific causes of death in KTRs...
7.
Vangala C, Pan J, Cotton R, Ramanathan V
Front Med (Lausanne)
. 2018 Aug;
5:211.
PMID: 30109232
The risk of mineral and bone disorders among patients with chronic kidney disease is substantially elevated, owing largely to alterations in calcium, phosphorus, vitamin D, parathyroid hormone, and fibroblast growth...
8.
Vangala C, Lenihan C, Montez-Rath M, Nair S, Navaneethan S, Ramanathan V, et al.
BMC Nephrol
. 2017 May;
18(1):145.
PMID: 28460645
Background: Basic and translational research supports beneficial effects of statins on bone metabolism. Clinical studies suggest that statin use may reduce the risk of hip fractures in the general population....
9.
Li L, Lau K, Ramanathan V, Orcutt S, Sansgiry S, Albo D, et al.
J Surg Res
. 2017 May;
210:204-212.
PMID: 28457330
Background: Ileostomy creation is associated with postoperative dehydration and readmission; however, the effect on renal function is unknown. Our goal was to characterize the impact of ileostomy creation on acute...
10.
Lenihan C, Nair S, Vangala C, Ramanathan V, Montez-Rath M, Winkelmayer W
Am J Kidney Dis
. 2016 Nov;
69(5):595-601.
PMID: 27866965
Background: Posttransplantation bone disease is a significant problem, with few well-evidenced therapeutic options. Proton pump inhibitors (PPIs) are associated with hip fracture in the general population and are widely prescribed...